132 related articles for article (PubMed ID: 38172469)
21. Effects of screening for colorectal cancer: Development, documentation and validation of a multistate Markov model.
Heisser T; Hoffmeister M; Brenner H
Int J Cancer; 2021 Apr; 148(8):1973-1981. PubMed ID: 33320964
[TBL] [Abstract][Full Text] [Related]
22. Change in incidence, characteristics and management of colorectal neuroendocrine tumours in the Netherlands in the last decade.
Kooyker AI; Verbeek WH; van den Berg JG; Tesselaar ME; van Leerdam ME
United European Gastroenterol J; 2020 Feb; 8(1):59-67. PubMed ID: 32213058
[TBL] [Abstract][Full Text] [Related]
23. Occurrence and characteristics of faecal immunochemical screen-detected cancers vs non-screen-detected cancers: Results from a Flemish colorectal cancer screening programme.
van de Veerdonk W; Hoeck S; Peeters M; Van Hal G; Francart J; De Brabander I
United European Gastroenterol J; 2020 Mar; 8(2):185-194. PubMed ID: 32213071
[TBL] [Abstract][Full Text] [Related]
24. Synthetic indicator of the impact of colorectal cancer screening programmes on incidence rates.
Zorzi M; Zappa M;
Gut; 2020 Feb; 69(2):311-316. PubMed ID: 31040168
[TBL] [Abstract][Full Text] [Related]
25. Effects of Organized Colorectal Cancer Screening on Cancer Incidence and Mortality in a Large Community-Based Population.
Levin TR; Corley DA; Jensen CD; Schottinger JE; Quinn VP; Zauber AG; Lee JK; Zhao WK; Udaltsova N; Ghai NR; Lee AT; Quesenberry CP; Fireman BH; Doubeni CA
Gastroenterology; 2018 Nov; 155(5):1383-1391.e5. PubMed ID: 30031768
[TBL] [Abstract][Full Text] [Related]
26. The impact of screening on the survival of colorectal cancer in Shanghai, China: a population based study.
Li X; Zhou Y; Luo Z; Gu Y; Chen Y; Yang C; Wang J; Xiao S; Sun Q; Qian M; Zhao G
BMC Public Health; 2019 Jul; 19(1):1016. PubMed ID: 31357981
[TBL] [Abstract][Full Text] [Related]
27. Long-Term Follow-up of the Italian Flexible Sigmoidoscopy Screening Trial.
Senore C; Riggi E; Armaroli P; Bonelli L; Sciallero S; Zappa M; Arrigoni A; Casella C; Crosta C; Falcini F; Ferrero F; Fracchia M; Giuliani O; Risio M; Russo AG; Visioli CB; Rosso S; Segnan N;
Ann Intern Med; 2022 Jan; 175(1):36-45. PubMed ID: 34748376
[TBL] [Abstract][Full Text] [Related]
28. A conceptual framework and metrics for evaluating multicomponent interventions to increase colorectal cancer screening within an organized screening program.
Subramanian S; Hoover S; Tangka FKL; DeGroff A; Soloe CS; Arena LC; Schlueter DF; Joseph DA; Wong FL
Cancer; 2018 Nov; 124(21):4154-4162. PubMed ID: 30359464
[TBL] [Abstract][Full Text] [Related]
29. Impact of the UK colorectal cancer screening pilot studies on incidence, stage distribution and mortality trends.
McClements PL; Madurasinghe V; Thomson CS; Fraser CG; Carey FA; Steele RJ; Lawrence G; Brewster DH
Cancer Epidemiol; 2012 Aug; 36(4):e232-42. PubMed ID: 22425027
[TBL] [Abstract][Full Text] [Related]
30. Colorectal cancer in Saudi Arabia: incidence, survival, demographics and implications for national policies.
Alsanea N; Abduljabbar AS; Alhomoud S; Ashari LH; Hibbert D; Bazarbashi S
Ann Saudi Med; 2015; 35(3):196-202. PubMed ID: 26409793
[TBL] [Abstract][Full Text] [Related]
31. Colorectal Cancer: A Collaborative Approach to Improve Education and Screening in a Rural Population
.
Woodall M; DeLetter M
Clin J Oncol Nurs; 2018 Feb; 22(1):69-75. PubMed ID: 29350693
[TBL] [Abstract][Full Text] [Related]
32. Association of Race and Socioeconomic Status With Colorectal Cancer Screening, Colorectal Cancer Risk, and Mortality in Southern US Adults.
Warren Andersen S; Blot WJ; Lipworth L; Steinwandel M; Murff HJ; Zheng W
JAMA Netw Open; 2019 Dec; 2(12):e1917995. PubMed ID: 31860105
[TBL] [Abstract][Full Text] [Related]
33. Incidence of Colorectal Cancer and Adenomatous Polyps After a Two-Step Screening in Isfahan Province, Iran in 2018.
Soodejani MT; Mirzaei H; Manesh MM; Tabatabaei SM; Ghaderi A
J Gastrointest Cancer; 2020 Sep; 51(3):850-854. PubMed ID: 31656018
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the colorectal cancer screening Programme in the Basque Country (Spain) and its effectiveness based on the Miscan-colon model.
Idigoras I; Arrospide A; Portillo I; Arana-Arri E; Martínez-Indart L; Mar J; de Koning HJ; Lastra R; Soto-Gordoa M; van der Meulen M; Lansdorp-Vogelaar I
BMC Public Health; 2017 Aug; 18(1):78. PubMed ID: 28764731
[TBL] [Abstract][Full Text] [Related]
35. Colorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in the Netherlands: a population-based study.
Breekveldt ECH; Lansdorp-Vogelaar I; Toes-Zoutendijk E; Spaander MCW; van Vuuren AJ; van Kemenade FJ; Ramakers CRB; Dekker E; Nagtegaal ID; Krul MF; Kok NFM; Kuhlmann KFD; Vink GR; van Leerdam ME; Elferink MAG;
Lancet Gastroenterol Hepatol; 2022 Jan; 7(1):60-68. PubMed ID: 34822762
[TBL] [Abstract][Full Text] [Related]
36. Colon Cancer Screening - Is It Time Yet?
Bhurgri H; Samiullah S
J Coll Physicians Surg Pak; 2017 Jun; 27(6):327-328. PubMed ID: 28689518
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness of a Mailed Colorectal Cancer Screening Outreach Program in Community Health Clinics: The STOP CRC Cluster Randomized Clinical Trial.
Coronado GD; Petrik AF; Vollmer WM; Taplin SH; Keast EM; Fields S; Green BB
JAMA Intern Med; 2018 Sep; 178(9):1174-1181. PubMed ID: 30083752
[TBL] [Abstract][Full Text] [Related]
38. Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up.
Scholefield JH; Moss SM; Mangham CM; Whynes DK; Hardcastle JD
Gut; 2012 Jul; 61(7):1036-40. PubMed ID: 22052062
[TBL] [Abstract][Full Text] [Related]
39. Higher Adenoma Detection Rates at Screening Associated With Lower Long-Term Colorectal Cancer Incidence and Mortality.
Cross AJ; Robbins EC; Saunders BP; Duffy SW; Wooldrage K
Clin Gastroenterol Hepatol; 2022 Feb; 20(2):e148-e167. PubMed ID: 32931959
[TBL] [Abstract][Full Text] [Related]
40. Incidence, Clinico-demographic Profiles and Survival Rates of Colorectal Cancer in Northern Malaysia: Comparing Patients Above and Below 50 Years of Age.
Wan Ibrahim NR; Chan HK; Soelar SA; Azmi AN; Mohd Said R; Abu Hassan MR
Asian Pac J Cancer Prev; 2020 Apr; 21(4):1057-1061. PubMed ID: 32334470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
